1
Clinical Trials associated with NK Cells(Xinxiang Medical University)Clinical Investigation of Natural Killer Cells Treatment in Pneumonia Patients Infected With 2019 Novel Coronavirus
Since december 2019, acute respiratory disease due to 2019 novel coronavirus (2019-nCoV) emerged in Wuhan city and rapidly spread throughout China. There is no confirmed antivirus therapy for 2019-nCoV infection. Natural killer (NK) cells are innate lymphocytes that may serve as useful effectors against danger infection. The purpose of this clinical investigation is to evaluate the safety and efficiency of NK Cells in combination with standard therapy for pneumonia patients infected with 2019-nCoV.
100 Clinical Results associated with NK Cells(Xinxiang Medical University)
100 Translational Medicine associated with NK Cells(Xinxiang Medical University)
100 Patents (Medical) associated with NK Cells(Xinxiang Medical University)
100 Deals associated with NK Cells(Xinxiang Medical University)